The importance of AST/ALT rate in nonalcoholic steatohepatitis diagnosis;A importância do índice AST/ALT no diagnóstico da esteatohepatite não-alcoólica

Arquivos de Gastroenterologia

Volumn 39, Issue 1, 2002, Pages 22-26

  Zamin Jr , Idilio ^a,b   De Mattos, Angelo Alves ^a   Perin, Christiano ^a   Ramos, Gabriel Zatti ^a  

^a UNIVERSIDADE FEDERAL DE CIÊNCIAS DA SAÚDE DE PORTO ALEGRE   (Brazil)

^b NONE   (Brazil)

Author keywords

Alanine transaminase; Alcoholic; Aspartate aminotransferases; Fatty liver; Hepatitits

Indexed keywords

ALANINE AMINOTRANSFERASE; ALCOHOL; ASPARTATE AMINOTRANSFERASE; BIOLOGICAL MARKER;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALCOHOL ABUSE; ALCOHOL LIVER DISEASE; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CONTROLLED STUDY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; FATTY LIVER; FEMALE; HEPATITIS; HUMAN; LIVER BIOPSY; LIVER DISEASE; LIVER NECROSIS; MAJOR CLINICAL STUDY; MALE; NONALCOHOLIC FATTY LIVER; OBESITY; STATISTICAL ANALYSIS; CASE CONTROL STUDY; ENZYME ASSAY; MIDDLE AGED; PROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY;

ADULT; ALANINE TRANSAMINASE; ASPARTATE AMINOTRANSFERASES; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; ENZYME TESTS; FATTY LIVER; FEMALE; HEPATITIS; HEPATITIS, ALCOHOLIC; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY;

EID: 0036052686     PISSN: 00042803     EISSN: None     Source Type: Journal    
DOI: 10.1590/s0004-28032002000100005     Document Type: Article

References (27)

1. Angulo P, Keach JC, Baits KP, Lindor KD. Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis. Hepatology 1999;6:1356-62.
2. Bacon BR, Farahvash MJ, Janney CG, Neuschwander-Tetri BA. Nonalcoholic steatohepatitis: an expanded clinical entity. Gastroenterology 1994;107:1103-9.
3. Baptista A, Bianchi L, Degroote J. Alcoholic liver disease: morphologic manifestations. Lancet 1981;1:707-11.
4. Bray GA. Obesity: definition, diagnosis and disadvantages. Med J Aust 1985;142:32-8.
5. Bruguera M, Bordas JM, Rodes J. Asymptomatic liver disease in alcoholics. Arch Pathol Lab Med 1977;101:644-7.
6. Caldwell SH, Oelsner DH, Iezzoni JC, Hespenheide EE, Battle EH, Driscoll CJ. Cryptogenic cirrhosis: clinical characterization and risk factors for underlying disease.Hepatology 1999;29:664-9.
7. Diehl AM, Goodman Z, Ishak KG. Alcohollike liver disease in nonalcoholics. A clinical and histologic comparison with alcohol-induced liver injury. Gastroenterology 1988;95:1056-62.
8. Fletcher LM, Kwoh-Gain I, Powell EE, Powell LW, Halliday JW. Markers of chronic alcohol ingestion in patients with nonalcoholic steatohepatitis: an aid to diagnosis. Hepatology 1991;13:455-9.
9. Itoh JE, Czaja AJ, Rakela J, Ludwig J. The nature of unexplained chronic aminotransferase elevations of a mild to moderate degree in asymptomatic patients. Hepatology 1989;9:193-7.
10. Itoh S, Yougel T, Kawagoe K. Comparison between nonalcoholic steatohepatitis and alcoholic hepatitis. Am J Gastroenterol 1987;82:650-4.
11. Lee RG. Nonalcoholic steatohepatitis: a study of 49 patients. Hum Pathol 1989;20:594-8.
12. Ludwig J, Viggiano TR, McGill DB, Ott BJ. Nonalcoholic steatohepatitis. Mayo Clinic experiences with a hitherto unnamed disease. Mayo Clin Proc 1980;55:434-8.
13. Ludwig J, McGill DB, Lindor KD. Review. Nonalcoholic steatohepatitis. J Gastroenterol Hepatol 1997;12:398-403.
14. Matteoni CA, Younossi ZM, Gramlich T, Boparai N, Liu YC, McCullough AJ. Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity. Gastroenterology 1999;116:1413-9.
15. Monteiro JC. Obesidade: diagnóstico, métodos e fundamentos. In: Monteiro JC. Obesidade. São Paulo: Lemos Editorial; 1998. p.31-53.
16. National Institutes of Health. Symposium on Non-alcoholic Steatohepatitis. Bethesda, Maryland; 1998. [Syllabus]
17. Nonomura A, Mizukami Y, Unoura M, Kobayashi K, Takeda Y, Takeda R. Clinicopathologic study of alcohol-like liver disease in non-alcoholics; non-alcoholic steatohepatitis and fibrosis. Gastroenterol Jpn 1992;27:521-8.
18. Pinto HC, Baptista A, Camilo ME, Valente A, Saragoça A, Moura MC. Nonalcoholic steatohepatitis. Clinicopathological comparison with alcoholic hepatitis in ambulatory and hospitalized patients. Dig Dis Sci 1996;41:172-9.
19. Poonawala A, Nair SP, Thuluvath PJ. Prevalence of obesity and diabetes in patients with cryptogenic cirrhosis: a case-control study. Hepatology 2000;32:689-92.
20. Powell EE, Cooksley WG, Hanson R, Searle J, Halliday JW, Powell LW. The natural history of nonalcoholic steatohepatitis: a follow-up study of forty-two patients for up to 21 years. Hepatology 1990;11:74-80.
21. Schaffner F, Adler M. Fatty liver hepatitis and cirrhosis in obese patients. Am J Med 1979;67:811-6.
22. Sheth SG, Gordon FD, Chopra S. Nonalcoholic steatohepatitis. Ann Intern Med 1997;126:137-45.
23. Sheth SG, Flamm SL, Gordon FD, Chopra S. AST/ALT ratio predicts cirrhosis in patients with chronic hepatitis C virus infection. Am J Gastroenterol 1998;93:44-8.
24. Sorbi D, Boynton J, Lindor KD. The ratio aspartato aminotransferase to alanine aminotransferase: potential value in differentiating nonalcoholic steatohepatitis from alcoholic liver disease. Am J Gastroenterol 1999;94:1018-22.
25. Teli MR, James OFW, Burt AD, Bennett MK, Day CP. The natural history of nonalcoholic fatty liver: a follow-up study. Hepatology 1995;22:1714-9.
26. Wanless IR, Lentz JS. Fatty liver hepatitis (steatohepatitis) and obesity: an autopsy study with analysis of risk factors. Hepatology 1990;12:1106-10.
27. Williams ALB, Hoofnagle JH. Ratio of serum aspartate to alanine aminotransferase in chronic hepatitis: relationship to cirrhosis. Gastroenterology 1988;95:734-9.